Prosecution Insights
Last updated: August 17, 2026
Application No. 18/571,761

PROCESS FOR THE SYNTHESIS OF PROPARGYLIC ALCOHOL BY REACTING FORMALDEHYDE WITH ACETYLENE IN THE PRESENCE OF A HOMOGENEOUS COPPER CATALYST

Non-Final OA §112§Other
Filed
Dec 19, 2023
Priority
Jun 21, 2021 — EU 21180528.8 +1 more
Examiner
RHOADES, DEREK JAMES
Art Unit
Tech Center
Assignee
BASF SE
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
53 granted / 75 resolved
+10.7% vs TC avg
Strong +17% interview lift
Without
With
+17.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
20 currently pending
Career history
87
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
43.2%
+3.2% vs TC avg
§102
13.9%
-26.1% vs TC avg
§112
23.0%
-17.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 75 resolved cases

Office Action

§112 §Other
DETAILED ACTION STATUS OF THE APPLICATION Receipt is acknowledged of Applicants’ Amendments and Remarks, filed 19 December 2023, in the matter of Application No. 18/571,761. Said documents have been entered on the record. The Examiner further acknowledges the following: The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 14-26 are pending. No claims have been amended. Claims 1-13 have been cancelled. Claims 14-26 have been newly added. Thus, claims 14-26 represent all claims currently under consideration. Priority Acknowledgment is made of Applicant’s claim for foreign priority under 35 U.S.C. 119 (a)-(d). The certified copy has been filed in the present application filed 19 December 2023 and in parent Application No. PCT/EP2022/065792, filed on 10 June 2022. Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Applicant claims foreign priority to Application No. EP 21180528.8, filed on 21 June 2021. Domestic Priority data as claimed by applicant: This application is a 371 of PCT/EP2022/065792 (06/10/2022) Foreign Applications: EUROPEAN PATENT 21180528.8 (06/21/2021) Information Disclosure Statement (IDS) The information disclosure statements submitted on 27 December 2023 and 10 March 2024 are in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statements are being considered by the Examiner. Claim Objections Claim 16 is objected to because of the following informalities: In lines 1-2, “…formula I or II… should read “…formula (I) or (II)…” In line 23, formula (III) and formula (IV) are blurry and it is difficult to read the variables and numbers associated with them. In line 24, “…m, q are…” should read “…where m, q are…” In line 45, “…Y1, Y2, Y3 are…” should read “…Y1, Y2, Y3 are…” Claim 17 is objected to because of the following informalities: In line 2, “…according formula V…” should read “…according to formula (V)…” A period is missing at the end of the sentence of the claim. Claim 18 is objected to because of the following informalities: In line 2, “…during the reaction of the formaldehyde with acetylene…” should read “…during the reaction of formaldehyde with acetylene …” Claim 19 is objected to because of the following informalities: A period is missing at the end of the sentence of the claim. Claim 21 is objected to because of the following informalities: In line 1, “…the reaction mixture…” should read “…the process…” Claim 22 is objected to because of the following informalities: In line 1, “…the reaction…” should read “…the process…” Claim 23 is objected to because of the following informalities: In line 1, “…the reaction…” should read “…the process…” Claim 24 is objected to because of the following informalities: In line 1, “…the reaction…” should read “…the process…” Claim 26 is objected to because of the following informalities: In line 2, “…organic phase is reused as catalyst…” should read “…organic phase and is reused as catalyst…” In line 2, “…the alkynylation reaction…” should read “…the process…” Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 17-18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 17 recites formula V, however there are no corresponding definitions for the variables Y1 and Y2. Therefore, the scope of the claimed genus is unclear, and this ambiguity renders the instant claim indefinite. Further clarification is required. The Examiner notes that adequately addressing this ambiguity would ameliorate this claim rejection. For the purposes of examination, the definition of variables Y1 and Y2 will be interpreted as defined in instant claim 16 and the written description (Specification; page 6, lines 1-6). Claim 18 recites the limitation “the copper complex” in line 1. There is insufficient antecedent basis for this limitation in the claim. Further clarification is required. The Examiner notes that correcting any suspected typographical error(s) regarding the claim language would ameliorate this claim rejection. Allowable Subject Matter Claims 14-15, 20, and 25 are allowed. Claims 16-19, 21-24, and 26 would be allowable if rewritten or amended to overcome the objections to claims 16-19, 21-24, and 26 and the rejections of claims 17-18 under 35 U.S.C. 112(b)/35 U.S.C. 112 (pre-AIA ), second paragraph, set forth in this Office Action. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record does not teach or suggest a process to produce propargylic alcohol comprising reacting acetylene with formaldehyde in a liquid phase in the presence of a copper catalyst and at least one phosphine, as recited in independent claim 14. The closest prior art to the claimed invention is Vicari et al. (US 2007/0112226 A1; IDS of 12-27-2023; hereinafter “Vicari”) and Asano et al. (“Enantioselective Addition of Terminal Alkynes to Aromatic Aldehydes Catalyzed by Copper(I) Complexes with Wide-Bite-Angle Chiral Bisphosphine Ligands: Optimization, Scope, and Mechanistic Studies”; Organometallics 2008, 27, 5984-5996; hereinafter “Asano”). Vicari teaches a method for the production of propargyl alcohol comprising reacting an aqueous formaldehyde solution and acetylene over a copper acetylide catalyst (Vicari; Title; Abstract; claim 1). Vicari fails to teach a process to produce propargylic alcohol comprising at least one phosphine. Asano teaches the addition of terminal alkynes to aldehydes in the presence of a Cu-phosphine complex to afford propargyl alcohols (Asano; Title; Abstract). Asano further teaches that wide bite angles of bisphosphine ligands are important for the activation of Cu catalysis toward the addition of terminal alkynes and aldehydes via deaggregation of Cu acetylides (Asano; Abstract; page 5985, Col. 1, paragraph 1). In addition, Asano demonstrates the catalytic activity of a Cu(I) complex with DBEPhos, Xantphos, DTBM-Xantphos, (S,S)-(R,R)Fc-Ph-TRAP, and (R,R)-i-Pr-DuPhos bisphosphine ligands for the addition of phenylacetylene to benzaldehyde in toluene solvent to afford the corresponding propargylic alcohol (Asano; page 5985; Table 1 and Figure 1, Col. 1, paragraph 3 and Col. 2, paragraph 1; page 5991, Col. 2, Conclusions paragraph). Asano fails to explicitly teach a method for the production of propargyl alcohol comprising reacting acetylene with formaldehyde. Although Vicari and Asano reside in the closely overlapping technical field of Cu-catalyzed addition reactions of terminal alkynes to aldehydes, the method of Asano utilizing Cu-phosphine catalysts does not disclose that formaldehyde is a viable substrate for the transformation, nor does Asano utilize acetylene as a reactant in the disclosed transformation. Of particular note, Asano teaches that the substrate scope is limited to aromatic aldehydes, and reports a 0% yield for non-aromatic aldehydes (Asano; page 5989, Table 7, entries 14-15). Thus, it would not be predictable for one of ordinary skill in the art to apply the catalytic system of Asano to the process of Vicari, because teaches away from the use of non-aromatic aldehydes as viable reactants. As such, the skilled artisan would not be sufficiently motivated to substitute the copper acetylide catalyst of Vicari with the Cu-phosphine catalyst of Asano with a reasonable expectation of success to arrive at the process of claim 14. Therefore, the claims are free from the prior art for the reasons of record and the reasons set forth above. Also see MPEP § 2143(B)(I). Conclusion Any inquiry concerning this communication or earlier communications from the Examiner should be directed to Derek Rhoades whose telephone number is (703)-756-5321. The Examiner can normally be reached Monday–Thursday, 7:30 am–5:00 pm EST; Friday, 7:30 am–4:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the Examiner’s supervisor, Scarlett Goon can be reached on 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.R./Examiner, Art Unit 1692 /AMY C BONAPARTE/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Dec 19, 2023
Application Filed
Jul 14, 2026
Non-Final Rejection mailed — §112, §Other (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703793
MARINE-BIODEGRADATION ACCELERATOR
3y 8m to grant Granted Aug 11, 2026
Patent 12698258
CYSTINE CATIONIC LIPIDS
4y 9m to grant Granted Aug 04, 2026
Patent 12698253
HETEROGENEOUS SYNTHESIS OF METHYLENE DIANILINE
4y 1m to grant Granted Aug 04, 2026
Patent 12698256
HYDROCARBON FUNCTIONALIZED POLYAMINES FOR CORROSION INHIBITION
4y 0m to grant Granted Aug 04, 2026
Patent 12691438
Catalyst
3y 11m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
88%
With Interview (+17.4%)
3y 7m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 75 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month